3200 Lakeside Dr.
Santa Clara
CA
95054
USA
(408) 845-3000
Related Content
Technology | Stents Bioresorbable| Dave Fornell
July 5, 2016 — The U.S. Food and Drug Administration (FDA) has cleared the first fully bioresorbable coronary stent for ...
July 05, 2016
Feature | Cardiovascular Business| Dave Fornell
April 28, 2016 — Abbott and St. Jude Medical Inc. announced a definitive agreement for Abbott to acquire St. Jude ...
April 28, 2016
Feature | Stents Bioresorbable| Dave Fornell
Bioresorbable stents have been one of the hottest new cardiovascular technologies discussed at cardiology meetings over ...
April 13, 2016
Gregg Stone, M.D., director of cardiovascular research and education at Columbia University Medical Center / New York ...
April 12, 2016
Feature | Stents Bioresorbable| Dave Fornell
March 15, 2016 — An independent panel of experts convened by the U.S. Food and Drug Administration (FDA) voted 9 to 0 ...
March 15, 2016
February 29, 2016 — Abbott has initiated a voluntary safety notice regarding the MitraClip Delivery System to reinforce ...
February 29, 2016
February 2, 2016 — Abbott announced that it has acquired private medical device company Kalila Medical Inc. Kalila ...
February 02, 2016
The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel is set to review data and offer ...
January 20, 2016
Tom Watson, clinical analyst for MDBuyLine, and DAIC Editor Dave Fornell discuss some of the new cardiovascular and ...
November 05, 2015October 30, 2015 — Results from a clinical trial showed that that the Abbott Absorb everolimus-eluting bioresorbable ...
October 30, 2015© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now